MedPath

Vascular Dysfunction in Offspring of Assisted Reproduction Technologies

Conditions
Infertility
Interventions
Diagnostic Test: Transthoracic echocardiography
Registration Number
NCT00837642
Lead Sponsor
University of Lausanne Hospitals
Brief Summary

The prevalence of infertility has been estimated at 9% worldwide. The steadily increasing use of assisted reproductive technologies (ART) has allowed millions of infertile couples to have children. These children make up for 1 to 4% of the population in developed countries. ART involves the manipulation of early embryos at a time when they may be particularly vulnerable to external disturbances. In line with this concept, studies in mice suggest that ART alters the activity of enzymes involved in the regulation of metabolic and cardiovascular homeostasis. Alternatively, infertility itself or the drugs used to stimulate ovulation may have adverse effects on the outcome of the offspring. The safety of ART for long-term health is, therefore, of utmost importance. Among the potential long-term consequences of ART, cardiovascular disease may represent an important candidate, but there is no information.

Investigators show that, children born after in vitro fertilization (IVF) present systemic and pulmonary vascular dysfunction at high-altitude when compared to age- and sex-matched control subjects. A 5 years follow-up study shows that premature vascular aegieng persist and evolve to arterial hypertension. Arterial hypertension may induce cardiac dysfunction.

Therefore, the major goal of this proposal is to assess cardiac function in apparently healthy participants born after ART.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Offspring of ART
  • Healthy
  • Born at term
Exclusion Criteria
  • Cardio-pulmonary malformations
  • Neuro-muscular malformations

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ART (Assited reproductive technologies)Transthoracic echocardiographyIn participants born after IVF will be performed a transthoracic echocardiography
ControlTransthoracic echocardiographyIn participants naturally conceived will be performed a transthoracic echocardiography
Primary Outcome Measures
NameTimeMethod
Cardiac function1 year

Ejection fraction \[%\]

Secondary Outcome Measures
NameTimeMethod
Left ventricular musce mass1 year

Left ventricular muscle mass \[g/m2\]

Trial Locations

Locations (1)

University Hospital

🇨🇭

Bern, BE, Switzerland

© Copyright 2025. All Rights Reserved by MedPath